Patterns of finasteride and dutasteride use in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort: effects of socio-demographic factors and a black box warning
Background: Five-alpha reductase inhibitors (5-ARIs), specifically finasteride and dutasteride, have been shown to significantly reduce prostate cancer incidence. However, these agents were also associated with a significant increase in the detection of high-grade prostate cancer leading to an FD...
Main Authors: | Jarrett A. Johnson, Paul F. Pinsky, Howard L. Parnes, Damali N. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
MRE Press
2022-01-01
|
Series: | Journal of Men's Health |
Subjects: | |
Online Access: | https://article.imrpress.com/journal/JOMH/18/1/10.31083/j.jomh1801019/1875-6859-18-1-019.pdf |
Similar Items
-
Frozen-Thawed Sperm Analysis of Benign Prostatic Hyperplasia Dogs Treated With Finasteride
by: Renato Bueno Flores, et al.
Published: (2022-06-01) -
The impact of combination therapy of Croton membranaceus and finasteride on benign prostatic hyperplasia (BHP) histo-morphology
by: George A. Asare, et al.
Published: (2024-05-01) -
US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
by: Haidar Al Saffar, et al.
Published: (2023-06-01) -
Prospective double-blind randomized controlled trial of terazosin, finasteride and allylestrenol in the management of benign prostatic hyperplasia
by: Madhu S Agrawal, et al.
Published: (2001-01-01) -
Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
by: Daisuke Gotoh, et al.
Published: (2022-09-01)